Regeneron Pharma (REGN) PT Raised to $761 at Baird
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $792.23 +1.37%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 21 | New: 48
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 21 | New: 48
Join SI Premium – FREE
Baird analyst Brian Skorney raised the price target on Regeneron Pharma (NASDAQ: REGN) to $761.00 (from $742.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Freedom Broker Downgrades Frequency Electronics, Inc. (FEIM) to Hold
- Adobe (ADBE) PT Lowered to $373 at Bernstein SocGen Group
- Delek US (DK) PT Raised to $81 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
